保荐人子公司中国中金财富证券有限公司跟投的获配股份数量为本次公开发行股份数量的2.00%，即 10,821,176股，获配金额为120,115,053.60元。限售期为自上市之日起24个月。 阿特斯最终募集资金净额较原计划多172,782.43万元(行使超额配售选择权之前)；262,845.46万元(全额行 使超额配售选择权之后)。2023年6月6日，阿特斯披露的招股说明书显示，公司拟募集资金400,000.00万 元，分别用于产能配套及扩充项目、嘉兴阿特斯光伏技术有限公司研究院建设项目、补充流动资金。 阿特斯上市发行费用总额为27,792.86万元(行使超额配售选择权之前)；27,815.77万元(全额行使超额配售 选择权之后)。其中，中国国际金融股份有限公司、华泰联合证券有限责任公司、东吴证券股份有限公 司获得承销费及保荐费17,264.15万元。 中国经济网北京5月14日讯阿特斯(688472.SH)今日收报9.63元，跌幅3.51%，总市值355.18亿元。目前该 股处于破发状态。 阿特斯于2023年6月9日在上交所科创板上市，超额配售选择权行使前，公开发行股份数量541,058,824 股，占发行后 ...

Core Viewpoint - The company, Shenhao Technology, reported significant declines in revenue and net profit for the year 2024, with a continued negative trend in the first quarter of 2025, indicating ongoing financial challenges and operational difficulties [1][2]. Financial Performance Summary - In 2024, the company achieved operating revenue of 158 million yuan, a decrease of 59.20% compared to 2023 [2][3]. - The net profit attributable to shareholders was -238 million yuan, worsening from -101 million yuan in the previous year, reflecting a decline of 135.81% [2][3]. - The net profit after deducting non-recurring gains and losses was -271 million yuan, compared to -129 million yuan in 2023, marking a decline of 109.39% [2][3]. - The net cash flow from operating activities was -20.67 million yuan, an improvement from -36.32 million yuan in the previous year, showing a 43.09% increase [2][3]. Q1 2025 Performance Summary - For the first quarter of 2025, the company reported operating revenue of 12.86 million yuan, a year-on-year increase of 62.18% [3]. - The net profit attributable to shareholders was -40.10 million yuan, compared to -33.03 million yuan in the same period last year, representing a decline of 21.40% [3]. - The net profit after deducting non-recurring gains and losses was -47.15 million yuan, worsening from -34.90 million yuan year-on-year, indicating a decline of 35.11% [3]. - The net cash flow from operating activities was -17.14 million yuan, a significant drop from a positive cash flow of 90.63 million yuan in the same period last year, reflecting a decline of 118.91% [3]. Company Background - Shenhao Technology was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on July 24, 2020, with an initial public offering of 20,407,000 shares at a price of 30.41 yuan per share [3]. - The total amount raised from the IPO was approximately 620.58 million yuan, with a net amount of 570 million yuan allocated for research and development and production projects [4][5].

Group 1 - The company has established and executed an insider information knowledge person registration system in compliance with relevant regulations such as the Securities Law of the People's Republic of China and the Management Measures for Information Disclosure of Listed Companies [1][2] - During the planning of the transaction, the company implemented necessary confidentiality measures, limiting the scope of sensitive information knowledge [1][2] - The company registered the insiders involved in the transaction and reported the list to the Shanghai Stock Exchange in a timely manner [1][2] Group 2 - The company created a transaction progress memorandum documenting specific stages and developments of the transaction, including discussions, communications, and participant details, which was also filed with the Shanghai Stock Exchange [2] - The independent financial advisor concluded that the company fulfilled its confidentiality obligations prior to legal disclosure, adhering to relevant laws, regulations, and company policies [2]

Group 1 - The core transaction involves Nanjing Chemical Fiber Co., Ltd. acquiring 100% of Nanjing Process Equipment Manufacturing Co., Ltd. through asset swaps, issuance of shares, and cash payments [1][2] - Huatai United Securities acts as the independent financial advisor for the transaction, confirming compliance with relevant regulations regarding the hiring of third parties [1][2] - The independent financial advisor found no evidence of direct or indirect paid hiring of third parties in the transaction, ensuring that all intermediary institutions hired by the listed company are legal and compliant [1][2] Group 2 - The listed company has engaged various intermediary institutions as required by law for the transaction, including financial advisors and review agencies [1][2] - The hiring of these intermediary institutions is deemed legal and compliant, with no undisclosed third-party hiring activities identified [1][2]

华泰联合证券有限责任公司 关于不存在《上市公司监管指引第 7 号——上市公司重大资 产重组相关股票异常交易监管》第十二条不得参与上市公司 重大资产重组情形的承诺 南京化纤股份有限公司（以下简称"公司"、 "上市公司"）拟通过资产置换、 华泰联合证券有限责任公司 年 月 日 发行股份及支付现金的方式购买南京工艺装备制造股份有限公司 100%股份，并 募集配套资金（以下简称"本次交易"）。华泰联合证券有限责任公司（以下简称 "本独立财务顾问"）作为上市公司本次交易的独立财务顾问，现根据《上市公 司监管指引第 7 号——上市公司重大资产重组相关股票异常交易监管》第十二条 之规定，就本公司及相关经办人员是否存在不得参与任何上市公司重大资产重组 的情形承诺如下： 本独立财务顾问及本独立财务顾问的经办人员不存在泄露本次交易内幕信 息以及利用本次交易信息进行内幕交易的情形，不存在因涉嫌本次交易相关的内 幕交易被立案调查或者立案侦查的情形，最近 36 个月内不存在因涉嫌与重大资 产重组相关的内幕交易被中国证券监督管理委员会作出行政处罚或者被司法机 关依法追究刑事责任的情形，不存在依据《上市公司监管指引第 7 号——上市公 司 ...

Group 1 - The core viewpoint of the report is to summarize the sponsorship and regulatory compliance of Hubei Huqiang Technology Co., Ltd. during its initial public offering (IPO) on the Sci-Tech Innovation Board [1] - The issuer, Hubei Huqiang Technology Co., Ltd., has a registered capital of 344.5 million yuan and was listed on December 6, 2021 [1] - The report outlines the responsibilities of the sponsor, Huatai United Securities, including due diligence, document preparation, and compliance with regulatory requirements [1][3] Group 2 - The net amount raised from the IPO was 2.8121508 billion yuan, allocated to various projects including the "New Nuclear Biochemical Emergency Rescue Protection Equipment Industrialization Production Base Project" [4] - As of 2024, the balance of the special account for raised funds was 1.69612742 billion yuan, which includes idle funds used for cash management [4] - The sponsor has issued independent opinions on the use of raised funds for the years 2021, 2022, and 2023, confirming compliance with relevant regulations and no violations in fund usage [6][7][13] Group 3 - The report details the continuous supervision activities conducted by the sponsor, including on-site inspections and reviews of the issuer's governance and fund usage [3][4] - The sponsor has issued 24 verification opinions during the supervision period, with no disapprovals noted [8] - The issuer has been responsive to regulatory inquiries and has made necessary corrections regarding financial reporting and fund management [10][11]

中国经济网北京5月12日讯迪哲医药(688192.SH)今日收报52.23元，跌幅7.36%。该股目前处于破发状 态。 迪哲医药于2021年12月10日在上交所科创板上市，发行股票4000.01万股，发行价格为52.58元/股。 迪哲医药首次公开发行股票募集资金总额为21.03亿元，扣除发行费用后募集资金净额为19.87亿元。迪 哲医药最终募集资金净额比原计划多2.03亿元。该公司于2021年12月7日披露的招股说明书显示，其拟 募集资金17.83亿元，拟分别用于新药研发项目和补充流动资金。 迪哲医药首次公开发行股票的保荐人(主承销商)为中信证券股份有限公司，保荐代表人为丁元、彭浏 用，联席主承销商为华泰联合证券有限责任公司。该公司发行费用总额为1.17亿元，其中，承销费及保 荐费9564.42万元。 迪哲医药4月22日发布的2023年度向特定对象发行A股股票上市公告书显示，根据立信会计师事务所(特 殊普通合伙)2025年4月10日出具的《验资报告》(信会师报字[2025]第ZA10726号)，本次发行最终获配发 行对象共计14名，发行价格为43.00元/股，本次发行数量为41,764,808股，募集资金总额 ...

Group 1 - The major shareholder, Ruizhong Life Insurance Co., Ltd., plans to reduce its stake in Hualan Co., Ltd. by up to 3,789,267 shares, representing 3.00% of the total share capital, within a three-month period starting from June 4, 2025 [1] - The reduction will occur through centralized bidding and block trading, with a maximum of 1,263,089 shares (1.00% of total share capital) to be sold via centralized bidding and 2,526,178 shares (2.00% of total share capital) via block trading [1] - Ruizhong Life Insurance is the second-largest shareholder of Hualan Co., Ltd., holding 21,956,522 shares, which accounts for 17.38% of the company's total share capital [2] Group 2 - Hualan Co., Ltd. was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on November 1, 2021, with an initial public offering of 33,666,667 shares at a price of 58.08 yuan per share, raising a total of 1.955 billion yuan [2] - The net proceeds from the IPO amounted to 1.804 billion yuan, exceeding the original plan by 1.254 billion yuan, which was intended for automation and intelligent factory renovation, research and development center construction, and working capital [2] - The total issuance costs for Hualan Co., Ltd. were 151 million yuan, with Huatai United Securities Co., Ltd. receiving 133 million yuan as underwriting and sponsorship fees [3]

Group 1 - The company Shandong Weigao Blood Purification Products Co., Ltd. has received approval for its initial public offering (IPO) of A-shares and will be listed on the main board [1][2] - The total number of shares to be issued is 41,139,407 shares, with an initial strategic placement of 4,113,940 shares, accounting for 10% of the total issuance [2] - The final strategic placement amount is 1,772,075 shares, approximately 4.31% of the total issuance, leading to a total of 28,259,832 shares available for offline and online distribution [2][3] Group 2 - The IPO price is set at 26.50 yuan per share, with the initial issuance of 11,107,500 shares scheduled for May 8, 2025 [2][3] - The online subscription received an oversubscription rate of approximately 7,518.35 times, prompting the activation of a mechanism to adjust the allocation between offline and online investors [2][3] - After the adjustment, the final allocation is 12,512,832 shares for offline investors (31.78%) and 26,854,500 shares for online investors (68.22%) [3] Group 3 - The final online winning rate for investors is approximately 0.03215719% [3] - Investors are required to fulfill their payment obligations by May 12, 2025, and must ensure sufficient funds in their accounts [4] - The company has established a lock-up period of 6 months for 10% of the shares allocated to strategic placement investors, while 90% of the shares will be tradable immediately after listing [5][6] Group 4 - The strategic placement includes a special asset management plan for the company's senior management and core employees, managed by Huatai Securities [6][7] - The total amount of funds committed by strategic placement investors has been received in full by the underwriter [7] - The online lottery for share allocation was conducted on May 9, 2025, with a total of 53,709 winning numbers announced [8][9]

华泰联合证券有限责任公司 B7栋401） 二〇二五年五月 华泰联合证券有限责任公司（以下简称"华泰联合"或"本财务顾问"） 接受四川能源发展集团有限责任公司（以下简称"四川能源发展集团"或"收 购人"）委托，担任四川能源发展集团收购四川省新能源动力股份有限公司 （以下简称"川能动力"或"上市公司"）之财务顾问，根据《上市公司收购 管理办法》《上市公司并购重组财务顾问业务管理办法》等有关规定，持续督 导期自川能动力公告收购报告书之日起至收购完成后的12个月止（即从2025年3 月6日至收购完成后的12个月止）。 收购的财务顾问，出具了从2025年3月6日至2025年3月31日期间（以下简称"本 持续督导期"）的持续督导意见（以下简称"本意见"）。本意见所依据的文 件、书面资料等由收购人、四川化工集团有限责任公司（以下简称"化工集 团"）及四川能投资本控股有限公司（以下简称"能投资本"）（以下合并简 称"收购人及其一致行动人"）与川能动力提供，收购人及其一致行动人与川 能动力保证对其真实性、准确性和完整性承担全部及连带责任。本财务顾问对 所发表意见的真实性、准确性和完整性负责。 一、交易资产的交付或者过户情况 关 ...